These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 9056591

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
    Bialer M, Midha KK.
    Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Status of generic substitution: problematic drug classes reviewed.
    Ross MB.
    Hosp Formul; 1989 Aug; 24(8):441-4, 447-9. PubMed ID: 10294356
    [Abstract] [Full Text] [Related]

  • 6. Some thoughts on drug interchangeability.
    Chow SC, Song F, Chen M.
    J Biopharm Stat; 2016 Aug; 26(1):178-86. PubMed ID: 26366703
    [Abstract] [Full Text] [Related]

  • 7. On TIER method for assessment of individual bioequivalence.
    Ju HL.
    J Biopharm Stat; 1997 Mar; 7(1):63-85. PubMed ID: 9056589
    [Abstract] [Full Text] [Related]

  • 8. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G.
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [Abstract] [Full Text] [Related]

  • 9. What makes a generic medication generic?
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2009 Dec; 47(12):17-20. PubMed ID: 20000278
    [Abstract] [Full Text] [Related]

  • 10. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, Yang Y, Yu LX, Woodcock J.
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [Abstract] [Full Text] [Related]

  • 11. Generic products of antiepileptic drugs (AEDs): is it an issue?
    Bialer M.
    Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY, Jiang W, Lionberger R, Wong J, Jones JW, Kane MA, Krumholz A, Temple R, Polli JE.
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [Abstract] [Full Text] [Related]

  • 15. [Generic drugs in psychopharmacology: pros and cons].
    Cuenca E, Zaragozá F.
    Actas Esp Psiquiatr; 1999 Sep; 27(6):351-7. PubMed ID: 10611558
    [Abstract] [Full Text] [Related]

  • 16. The effect of generic competition on the price of brand-name drugs.
    Lexchin J.
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [Abstract] [Full Text] [Related]

  • 17. Assessing bioequivalence and drug interchangeability.
    Chen M, Chow SC.
    J Biopharm Stat; 2017 Apr; 27(2):272-281. PubMed ID: 27936343
    [Abstract] [Full Text] [Related]

  • 18. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
    Kwo EC, Kamat P, Steinman MA.
    Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
    [Abstract] [Full Text] [Related]

  • 19. [Bioequivalence and generics of index drugs with narrow therapeutic margins].
    Le Corre P.
    Presse Med; 2010 Feb; 39(2):169-76. PubMed ID: 19932591
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.